The bill would create a nonprofit Foundation for Enabling Biotechnology Innovation under the National Science Foundation Director. Its mission would be to help speed the commercialization of biotechnology products in the United States. It could support partnerships, research, public outreach, training, and work between federal agencies and other groups. The Foundation could not regulate biotechnology products. The bill sets rules for its board, finances, conflicts of interest, and public reporting.
The Foundation could offer studies, grants, education, and fellowship programs related to bringing biotechnology products to market. The bill does not specify who would qualify for these programs or describe direct benefits for the public.
The bill authorizes $4 million per year for the National Science Foundation starting in fiscal year 2026. It directs the agency to transfer at least $4 million per year to the Foundation from those appropriated amounts. The Foundation could also accept private support, but not from a foreign country or entity of concern. The bill does not state how much funding would ultimately be provided.
No publicly available information.
No publicly available information.